No Data
[Brokerage Focus] BOCOM INTL points to new opportunities in the medical Sector driven by AI technology, focusing on innovation related to AI and opportunities for valuation recovery.
Jingu Finance News | BOCOM INTL stated that multiple pharmaceutical companies have integrated DeepSeek, accelerating the implementation of AI + Medical Services. Many companies in the digital medical field, such as Yidu Technology, announced the integration of DeepSeek-R1 model, and Jiangsu Hengrui Pharmaceuticals and INNOVENT BIO also indicated that they will fully carry out DeepSeek application work. Moreover, the National Healthcare Security Administration has reiterated the reform of payment collection. The administration mentioned the achievements of the settlement reform in Jiangxi Province, where the payment collection cycle for medical supply companies has reduced from half a year to 30 days. The bank pointed out that AI large models empower digital medical services companies, showing significant potential in disease diagnosis/detection. At the same time,
Hong Kong stock movement | Jing Tai Holdings-P (02228) rose over 6% again as the AI pharmaceutical field continues to thrive, and the Industry is expected to enter a "qualitative change" stage.
Jingtai Holdings-P (02228) increased by over 6% again, reaching a rise of 6.27% as of the time of publication, priced at 7.12 HK dollars, with a transaction amount of 0.269 billion HK dollars.
Guotou Securities: AI pharmaceuticals have entered a "qualitative change" stage, and commercialization applications are expected to be realized.
With the increase in the success rate of AI pharmaceutical research and development, AI drug manufacturing is expected to enter the stage of commercial realization. In terms of investment, it is recommended to focus on positive progress in areas such as technology platforms, collaborative projects, clinical milestones, and research and development pipelines.
Hong Kong stocks are moving differently | AI Medical Concept stocks strengthened in early trading. AI empowers the pharmaceutical and Medical sectors to achieve continuous new progress. Several Medical companies have expressed their intention to connect w
AI Medical Concept stocks showed strength in the early session. As of the time of writing, Yidu Technology (02158) rose by 20.64% to HKD 7.19; MEDBOT-B (02252) increased by 19.45% to HKD 18.3; Crystal Technology Holdings-P (02228) climbed by 12.35% to HKD 6.64.
JingTai Technology strategically invests in RuanSheng Bio, a strong alliance to accelerate the development of Innovative Drugs.
Shenzhen, February 10, 2025 /PR Newswire/ -- On February 10, 2025, Crystal Tech (Crystal Holding-P, XTALPI-P, 2228.HK) announced the completion of a strategic investment in Alternative Bio and established deep research and development cooperation. Both parties are jointly advancing the research and development of Innovative Drugs based on the First-in-Class targets discovered by Alternative Bio in areas with unmet clinical needs Globally. Crystal Tech, as a pioneer in the AI drug development field, has AI + Siasun Robot&Automation technology.
Statistics on the abnormal changes in the Hong Kong Stock Connect share | February 10
Statistics on the fluctuation of Hong Kong Stock Connect share | February 7, 2025
